Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wetter, Spencer
and
Murphy, Claire
1999.
Individuals with Down's syndrome demonstrate abnormal olfactory event-related potentials.
Clinical Neurophysiology,
Vol. 110,
Issue. 9,
p.
1563.
Terai, K
Iwai, A
Kawabata, S
Tasaki, Y
Watanabe, T
Miyata, K
and
Yamaguchi, T
2001.
β-amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Neuroscience,
Vol. 104,
Issue. 2,
p.
299.
Wetter, Spencer
and
Murphy, Claire
2001.
Apolipoprotein E ε4 positive individuals demonstrate delayed olfactory event-related potentials.
Neurobiology of Aging,
Vol. 22,
Issue. 3,
p.
439.
Gold, Gabriel
Kövari, Enikö
Corte, Gina
Herrmann, François R.
Canuto, Alessandra
Bussière, Thierry
Hof, Patrick R.
Bouras, Constantin
and
Giannakopoulos, Panteleimon
2001.
Clinical Validity of Aß-Protein Deposition Staging in Brain Aging and Alzheimer Disease.
Journal of Neuropathology & Experimental Neurology,
Vol. 60,
Issue. 10,
p.
946.
Capsoni, Simona
Giannotta, Sabina
and
Cattaneo, Antonino
2002.
β-Amyloid Plaques in a Model for Sporadic Alzheimer's Disease Based on Transgenic Anti-Nerve Growth Factor Antibodies.
Molecular and Cellular Neuroscience,
Vol. 21,
Issue. 1,
p.
15.
Nijjar, Rani K
and
Murphy, Claire
2002.
Olfactory impairment increases as a function of age in persons with Down syndrome.
Neurobiology of Aging,
Vol. 23,
Issue. 1,
p.
65.
Thompson, Paul M.
Hayashi, Kiralee M.
de Zubicaray, Greig
Janke, Andrew L.
Rose, Stephen E.
Semple, James
Herman, David
Hong, Michael S.
Dittmer, Stephanie S.
Doddrell, David M.
and
Toga, Arthur W.
2003.
Dynamics of Gray Matter Loss in Alzheimer's Disease.
The Journal of Neuroscience,
Vol. 23,
Issue. 3,
p.
994.
Thompson, Paul M
Hayashi, Kiralee M
de Zubicaray, Greig I
Janke, Andrew L
Rose, Stephen E
Semple, James
Hong, Michael S
Herman, David H
Gravano, David
Doddrell, David M
and
Toga, Arthur W
2004.
Mapping hippocampal and ventricular change in Alzheimer disease.
NeuroImage,
Vol. 22,
Issue. 4,
p.
1754.
Noda-Saita, Kyoko
Terai, Kazuhiro
Iwai, Akihiko
Tsukamoto, Mina
Shitaka, Yoshitsugu
Kawabata, Shigeki
Okada, Masamichi
and
Yamaguchi, Tokio
2004.
Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer?s disease.
Acta Neuropathologica,
Vol. 108,
Issue. 5,
p.
435.
Pai, Ming‐Chyi
and
Jacobs, W. Jake
2004.
Topographical disorientation in community‐residing patients with Alzheimer's disease.
International Journal of Geriatric Psychiatry,
Vol. 19,
Issue. 3,
p.
250.
Thompson, Paul M.
Hayashi, Kiralee M.
de Zubicaray, Greig
Janke, Andrew L.
Sowell, Elizabeth R.
Rose, Stephen E.
Semple, James
Herman, David
Hong, Michael S.
Dittmer, Stephanie S.
Doddrell, David M.
and
Toga, Arthur W.
2004.
The Living Brain and Alzheimer’s Disease.
p.
87.
Buckner, Randy L.
2004.
Memory and Executive Function in Aging and AD.
Neuron,
Vol. 44,
Issue. 1,
p.
195.
Woodhouse, Adele
West, Adrian K.
Chuckowree, Jyoti A.
Vickers, James C.
and
Dickson, Tracey C.
2005.
Does β-amyloid plaque formation cause structural injury to neuronal processes?.
Neurotoxicity Research,
Vol. 7,
Issue. 1-2,
p.
5.
Noureddine, Maher A.
Li, Yi‐Ju
van der Walt, Joelle M.
Walters, Robert
Jewett, Rita M.
Xu, Hong
Wang, Tianyuan
Walter, Jeffrey W.
Scott, Burton L.
Hulette, Christine
Schmechel, Don
Stenger, Judith E.
Dietrich, Fred
Vance, Jeffery M.
and
Hauser, Michael A.
2005.
Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra.
Movement Disorders,
Vol. 20,
Issue. 10,
p.
1299.
Araujo, Joseph A.
Studzinski, Christa M.
Head, Elizabeth
Cotman, Carl W.
and
Milgram, Norton W.
2005.
Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.
AGE,
Vol. 27,
Issue. 1,
p.
27.
Sultana, Rukhsana
Ravagna, Agrippino
Mohmmad‐Abdul, Hafiz
Calabrese, Vittorio
and
Butterfield, D. Allan
2005.
Ferulic acid ethyl ester protects neurons against amyloid β‐ peptide(1–42)‐induced oxidative stress and neurotoxicity: relationship to antioxidant activity.
Journal of Neurochemistry,
Vol. 92,
Issue. 4,
p.
749.
Janelsins, Michelle C
Mastrangelo, Michael A
Oddo, Salvatore
LaFerla, Frank M
Federoff, Howard J
and
Bowers, William J
2005.
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice.
Journal of Neuroinflammation,
Vol. 2,
Issue. 1,
Ahn, J.
Um, M.
Choi, W.
Kim, S.
and
Ha, T.
2006.
Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by β-amyloid peptide 25–35 in young mice.
Biogerontology,
Vol. 7,
Issue. 4,
p.
239.
Villemagne, V.L.
Ng, S.
Cappai, R.
Barnham, K.J.
Fodero-Tavoletti, M.T.
Rowe, C.C.
and
Masters, C.L.
2006.
La Lunga Attesa: Towards a Molecular Approach to Neuroimaging and Therapeutics in Alzheimer's Disease.
The Neuroradiology Journal,
Vol. 19,
Issue. 4,
p.
453.
Wald, Lawrence L.
Fischl, Bruce
and
Rosen, Bruce R.
2006.
Ultra High Field Magnetic Resonance Imaging.
Vol. 26,
Issue. ,
p.
343.